BrainStorm Cell Therapeutics In
BCLI·10501E201·US·Common Stock·Healthcare - Biotechnology
BCLI (BrainStorm Cell Therapeutics In) is held by 2 institutional investors as of Q3 2025. Largest holders: OSAIC HOLDINGS, INC. ($1,351), Steward Partners Investment Advisory, LLC ($80). Net institutional sentiment: Bearish.
2
Holders
(1 Elite)
$1,431
Total Value
0% (14)
Consensus
0 buying - 14 selling
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold BCLI.
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer